PANW vs. REGN
PANW (Palo Alto Networks, Inc.) and REGN (Regeneron Pharmaceuticals, Inc.) are both stocks. PANW operates in Software - Infrastructure (Technology), while REGN operates in Biotechnology (Healthcare). Over the past 10 years, PANW returned 28.21%/yr vs 4.61%/yr for REGN. At a 0.24 correlation, their price movements are largely independent.
Performance
PANW vs. REGN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PANW achieves a 51.60% return, which is significantly higher than REGN's -18.32% return. Over the past 10 years, PANW has outperformed REGN with an annualized return of 28.21%, while REGN has yielded a comparatively lower 4.61% annualized return.
PANW
- 1D
- -0.42%
- 1M
- 51.78%
- YTD
- 51.60%
- 6M
- 42.71%
- 1Y
- 43.89%
- 3Y*
- 35.04%
- 5Y*
- 36.21%
- 10Y*
- 28.21%
REGN
- 1D
- 1.58%
- 1M
- -10.34%
- YTD
- -18.32%
- 6M
- -12.78%
- 1Y
- 30.36%
- 3Y*
- -5.46%
- 5Y*
- 4.37%
- 10Y*
- 4.61%
PANW vs. REGN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PANW Palo Alto Networks, Inc. | 51.60% | 1.23% | 23.41% | 111.32% | -24.81% | 56.66% | 53.68% | 22.78% | 29.95% | 15.91% |
REGN Regeneron Pharmaceuticals, Inc. | -18.32% | 8.96% | -18.90% | 21.73% | 14.25% | 30.72% | 28.66% | 0.53% | -0.65% | 2.42% |
Correlation
The correlation between PANW and REGN is -0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Jul 23, 2012 | 0.24 |
The correlation between PANW and REGN shifts across timeframes, from -0.10 (1 year) to 0.24 (all time), reflecting how their relationship changes across market environments.
Fundamentals
PANW:
$207.76B
REGN:
$67.71B
PANW:
$1.17
REGN:
$41.05
PANW:
238.15
REGN:
15.32
PANW:
18.92
REGN:
4.54
PANW:
7.51
REGN:
2.15
PANW:
$10.61B
REGN:
$14.92B
PANW:
$7.63B
REGN:
$12.61B
PANW:
$1.33B
REGN:
$5.74B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PANW vs. REGN — Risk / Return Rank
PANW
REGN
PANW vs. REGN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Palo Alto Networks, Inc. (PANW) and Regeneron Pharmaceuticals, Inc. (REGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PANW | REGN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.22 | ||
| Sortino ratioReturn per unit of downside risk | +0.15 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.18 | +0.03 |
| Calmar ratioReturn relative to maximum drawdown | 1.22 | 1.18 | +0.04 |
| Martin ratioReturn relative to average drawdown | 2.79 | 4.09 | -1.30 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PANW | REGN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.15 | 0.93 | +0.22 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.87 | 0.14 | +0.73 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.73 | 0.14 | +0.59 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.72 | 0.16 | +0.56 |
Drawdowns
PANW vs. REGN - Drawdown Comparison
The maximum PANW drawdown since its inception was -47.98%, smaller than the maximum REGN drawdown of -91.81%. Use the drawdown chart below to compare losses from any high point for PANW and REGN.
Loading charts...
Drawdown Indicators
| PANW | REGN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -47.98% | -91.81% | +43.83% |
Max Drawdown (1Y)Largest decline over 1 year | -36.01% | -25.85% | -10.16% |
Max Drawdown (3Y)Largest decline over 3 years | -36.01% | -59.69% | +23.68% |
Max Drawdown (5Y)Largest decline over 5 years | -36.01% | -59.69% | +23.68% |
Max Drawdown (10Y)Largest decline over 10 years | -47.98% | -59.69% | +11.71% |
Current DrawdownCurrent decline from peak | -7.07% | -47.25% | +40.18% |
Average DrawdownAverage peak-to-trough decline | -14.69% | -42.39% | +27.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.80% | 7.45% | +8.35% |
Volatility
PANW vs. REGN - Volatility Comparison
Palo Alto Networks, Inc. (PANW) has a higher volatility of 16.96% compared to Regeneron Pharmaceuticals, Inc. (REGN) at 12.54%. This indicates that PANW's price experiences larger fluctuations and is considered to be riskier than REGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PANW | REGN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.96% | 12.54% | +4.42% |
Volatility (6M)Calculated over the trailing 6-month period | 31.66% | 22.39% | +9.27% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.38% | 32.85% | +5.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 41.63% | 30.77% | +10.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 38.57% | 32.16% | +6.41% |
Dividends
PANW vs. REGN - Dividend Comparison
PANW has not paid dividends to shareholders, while REGN's dividend yield for the trailing twelve months is around 0.58%.
| Position | TTM | 2025 |
|---|---|---|
PANW Palo Alto Networks, Inc. | 0.00% | 0.00% |
REGN Regeneron Pharmaceuticals, Inc. | 0.58% | 0.46% |
Financials
PANW vs. REGN - Financials Comparison
This section allows you to compare key financial metrics between Palo Alto Networks, Inc. and Regeneron Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PANW vs. REGN - Profitability Comparison
PANW - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Palo Alto Networks, Inc. reported a gross profit of 2.03B and revenue of 3.00B. Therefore, the gross margin over that period was 67.6%.
REGN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Regeneron Pharmaceuticals, Inc. reported a gross profit of 2.94B and revenue of 3.61B. Therefore, the gross margin over that period was 81.4%.
PANW - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Palo Alto Networks, Inc. reported an operating income of -186.00M and revenue of 3.00B, resulting in an operating margin of -6.2%.
REGN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Regeneron Pharmaceuticals, Inc. reported an operating income of 642.90M and revenue of 3.61B, resulting in an operating margin of 17.8%.
PANW - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Palo Alto Networks, Inc. reported a net income of -177.00M and revenue of 3.00B, resulting in a net margin of -5.9%.
REGN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Regeneron Pharmaceuticals, Inc. reported a net income of 727.20M and revenue of 3.61B, resulting in a net margin of 20.2%.
Frequently Asked Questions
PANW and REGN have a correlation of -0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PANW has higher volatility (16.96%) compared to REGN (12.54%). In terms of maximum drawdown, PANW dropped -47.98% vs REGN's -91.81%.
PANW currently has the higher Sharpe Ratio (1.15 vs 0.93), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PANW and REGN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer